PGI22 ESTIMATING DIAGNOSTIC COSTS ASSOCIATED WITH A SECOND-GENERATION BLOOD TEST FOR ANTI-VINCULIN AND ANTI-CYTOLETHAL DISTENDING TOXIN B (CDTB) BIOMARKERS IN COMPARISON TO THE STANDARD EXCLUSIONARY APPROACH FOR IRRITABLE BOWEL SYNDROME WIT ...
May 1, 2020, 00:00
10.1016/j.jval.2020.04.378
https://www.valueinhealthjournal.com/article/S1098-3015(20)30566-0/fulltext
Title :
PGI22 ESTIMATING DIAGNOSTIC COSTS ASSOCIATED WITH A SECOND-GENERATION BLOOD TEST FOR ANTI-VINCULIN AND ANTI-CYTOLETHAL DISTENDING TOXIN B (CDTB) BIOMARKERS IN COMPARISON TO THE STANDARD EXCLUSIONARY APPROACH FOR IRRITABLE BOWEL SYNDROME WIT ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30566-0&doi=10.1016/j.jval.2020.04.378
First page :
Section Title :
Open access? :
No
Section Order :
10244